Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 12
Submit an article Journal homepage
308
Views
13
CrossRef citations to date
0
Altmetric
Theme: Thrombosis - Reviews

Thrombolysis for iliofemoral deep venous thrombosis

Anthony J ComerotaUniversity of Michigan, Section of Vascular Surgery, 1500 E. Medical Center Dr, Ann Arbor, MI 48109, USA;Jobst Vascular Institute, 2109 Hughes Dr Suite 400, Toledo, OH 43606, USACorrespondence[email protected]
&
Vijay KamathJobst Vascular Institute, 2109 Hughes Dr Suite 400, Toledo, OH 43606, USA
Pages 1631-1638 | Published online: 10 Jan 2014

References

  • Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch. Intern. Med. 164(1), 17–26 (2004).
  • Prandoni P, Lensing AW, CogoA et al. The long-term clinical course of acute deep venous thrombosis. Ann. Intern. Med. 125(1), 1–7 (1996).
  • Siragusa S, Malato A, Anastasio R et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the duration of anticoagulation based on compression ultrasonography (DACUS) study. Blood 112(3), 511–515 (2008).
  • Cosmi B, Legnani C, Iorio A et al. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur. J. Vasc. Endovasc. Surg. 39(3), 356–365 (2010).
  • O’Donnell TF, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J. Surg. Res. 22(5), 483–488 (1977).
  • Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur. J. Vasc. Surg. 4(1), 43–48 (1990).
  • Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann. Surg. 239(1), 118–126 (2004).
  • Nicolaides AN, Schull K, Fernandes E. Ambulatory venous pressure: new information. In: Investigation of Vascular Disorders. Nicolaides AN, Yao JS ( Eds). Churchill Livingstone, New York,NY, USA, 488–494 (1981).
  • Labropoulos N, Volteas N, Leon M et al. The role of venous outflow obstruction in patients with chronic venous dysfunction. Arch. Surg. 132(1), 46–51 (1997).
  • Linton RR. The post-thrombotic ulceration of the lower extremity: its etiology and surgical treatment. Ann. Surg. 138(3), 415–433 (1953).
  • Kahn SR, Shrier I, Julian JA et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann. Intern. Med. 149(10), 698–707 (2008).
  • Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE Jr. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J. Vasc. Surg. 18(4), 596–605 (1993).
  • Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J. Clin. Pathol. 27(7), 517–528 (1974).
  • Sevitt S. The mechanisms of canalisation in deep vein thrombosis. J.Pathol. 110(2), 153–165 (1973).
  • Brooks EG, Trotman W, Wadsworth MP et al. Valves of the deep venous system: an overlooked risk factor. Blood 114(6), 1276–1279 (2009).
  • Bjarnason H, Kruse JR, Asinger DA et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J. Vasc. Interv. Radiol. 8(3), 405–418 (1997).
  • Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology211(1), 39–49 (1999).
  • Comerota AJ, Kagan SA. Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis. Phlebology 15, 149–155 (2000).
  • Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J. Vasc. Surg. 32(1), 130–137 (2000).
  • Mathias SD, Prebil LA, Putterman CG, Chmiel JJ, Throm RC, Comerota AJ. A health-related quality of life measure in patients with deep vein thrombosis: a validation study. Drug Inf. J. 33(4), 1173–1187 (1999).
  • Broholm R, Sillesen H, Damsgaard MT et al. Postthrombotic syndrome and quality of life in patients with iliofemoral venous thrombosis treated with catheter-directed thrombolysis. J. Vasc. Surg. 54(Suppl. 6), 18S–25S (2011).
  • Grewal N, Martinez J, Andrews L, Comerota AJ. Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with post-thrombotic morbidity. J. Vasc. Surg. 51(5), 1209–1214 (2010).
  • Baekgaard N, Broholm R, Just S, Jorgensen M, Jensen LP. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur. J. Vasc. Endovasc. Surg. 39(1), 112–117 (2010).
  • Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur. J. Vasc. Endovasc. Surg. 24(3), 209–214 (2002).
  • Enden T, Haig Y, Klow NE et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 379(9810), 31–38 (2012).
  • Comerota AJ. The ATTRACT Trial: rationale for early intervention for iliofemoral DVT. Perspect. Vasc. Surg. Endovasc. Ther. 21(4), 221–224 (2009).
  • Enden T, Resch S, White C, Wik HS, Klow NE, Sandset PM. Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. J. Thromb. Haemost. 11(6), 1032–1042 (2013).
  • Sillesen H, Just S, Jorgensen M, Baekgaard N. Catheter-directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency. Eur. J. Vasc. Endovasc. Surg. 30(5), 556–562 (2005).
  • Vedantham S, Vesely TM, Parti N, Darcy M, Hovsepian DM, Picus D. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J. Vasc. Interv. Radiol. 13(10), 1001–1008 (2002).
  • Lin PH, Zhou W, Dardik A et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am. J. Surg. 192(6), 782–788 (2006).
  • Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J. Vasc. Interv. Radiol. 12(2), 179–185 (2001).
  • Parikh S, Motarjeme A, McNamara T et al. Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J. Vasc. Interv. Radiol. 19(4), 521–528 (2008).
  • Martinez Trabal JL, Comerota AJ, LaPorte FB, Kazanjian S, DiSalle R, Sepanski DM. The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis (ISPMT) for iliofemoral venous thrombosis. J. Vasc. Surg. 48(6), 1532–1537 (2008).
  • Vogel D, Walsh ME, Chen JT, Comerota AJ. Comparison of vein valve function following pharmacomechanical thrombolysis versus simple catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J. Vasc. Surg. 56(5), 1351–1354 (2012).
  • Gasparis AP, Labropoulos N, Tassiopoulos AK et al. Midterm follow-up after pharmacomechanical thrombolysis for lower extremity deep venous thrombosis. Vasc. Endovascular Surg. 43(1), 61–68 (2009).
  • Comerota AJ, Grewal N, Martinez JT et al. Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J. Vasc. Surg. 55(3), 768–773 (2012).
  • Aziz F, Comerota AJ. Quantity of residual thrombus after successful catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with recurrence. Eur. J. Vasc. Endovasc. Surg. 44(2), 210–213 (2012).
  • Prandoni P, Noventa F, Ghirarduzzi A et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 92(2), 199–205 (2007).
  • Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am. J. Med. 110(7), 515–519 (2001).
  • Palareti G, Legnani C, Cosmi B et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108(3), 313–318 (2003).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.